We have read with great interest the article recently published in your journal under the title 'High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?' by Pinetron de Cambrun et al. [1]. This article retrospectively describes a series of 25 patients with acute respiratory distress syndrome (ARDS) associated with COVID-19 admitted to the ICU of a tertiary hospital. They found a high prevalence of antiphospholipid antibodies (aPL), which led them to suspect a specific induction of these aPL by SARS-CoV-2 and an association with the prothrombotic state triggered by this disease. Potential need for early anticoagulation therapy for all patients with COVID-19 is suggested on the basis of these findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.